GO:1905638 negative regulation of mitochondrial mRNA catabolic process: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905638 describes any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial mRNA catabolic process, thereby stabilizing mitochondrial transcripts and supporting oxidative phosphorylation capacity.
• Mitochondrial mRNA stability is controlled by nuclear-encoded RNA-binding proteins and by mitochondrial topoisomerase I, which can negatively regulate mitochondrial transcription and indirectly influence transcript turnover [4,7].
• ALDH2-LIN28B-ELK3 signaling improves endothelial barrier function and is linked to early abdominal aortic aneurysm progression, illustrating how RNA stability pathways intersect with mitochondrial mRNA regulation.
• CELF1 stabilizes Dio2 mRNA in adipocytes to promote beiging of white fat, demonstrating that mRNA stabilization programs are central to metabolic remodeling.
• Ferroptosis-mediated energy metabolism disorders in colorectal cancer can be suppressed by berberine, connecting mitochondrial mRNA regulation to cancer cell death pathways.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect whether candidate genes causally regulate mitochondrial mRNA stability in disease contexts [5,6].
Description
GO:1905638, negative regulation of mitochondrial mRNA catabolic process, is a biological process term that captures any mechanism which stops, prevents or reduces the frequency, rate or extent of mitochondrial mRNA catabolic process. Mitochondria contain their own genome, and the stability of mitochondrial mRNAs directly determines the availability of transcripts for the organelle's translation machinery. Because mitochondrial gene expression is essential for oxidative phosphorylation, factors that slow mitochondrial mRNA decay can reshape cellular energetics and stress responses [4,7]. The term is therefore of interest to researchers studying mitochondrial biogenesis, metabolic disease, neurodegeneration and cancer, where transcript stability often determines whether cells survive or die [1,3,8]. Mechanistically, negative regulation of mitochondrial mRNA catabolic process can be achieved by RNA-binding proteins that shield transcripts from nucleases, by changes in mitochondrial RNA granule composition, or by transcriptional feedback that reduces the pool of transcripts available for degradation [4,7]. For example, mitochondrial topoisomerase I negatively regulates mitochondrial transcription, which in turn alters the steady-state levels of mitochondrial mRNAs and their catabolic flux. In skeletal muscle differentiation, Tfam expression is regulated to match mitochondrial transcript demand, showing that the balance between synthesis and decay is developmentally controlled. In disease, dysregulation of mitochondrial mRNA stability contributes to endothelial barrier failure in abdominal aortic aneurysm, to metabolic disorders of adipose tissue, and to ferroptosis sensitivity in colorectal cancer [1,2,3]. Drosophila models of amyotrophic lateral sclerosis show imbalanced mitochondrial dynamics, highlighting the importance of mitochondrial RNA regulation in neurodegeneration. Understanding GO:1905638 therefore requires integrating RNA biology, mitochondrial physiology and disease genetics [5,6].
negative regulation of mitochondrial mRNA catabolic process At A Glance
| GO ID | GO:1905638 |
|---|---|
| GO term | negative regulation of mitochondrial mRNA catabolic process |
| Ontology | biological_process |
| Synonym | down regulation of mitochondrial mRNA catabolic process; down-regulation of mitochondrial mRNA catabolic process; downregulation of mitochondrial mRNA catabolic process; inhibition of mitochondrial mRNA catabolic process |
| Major function | Stabilizes mitochondrial mRNAs by reducing their catabolic rate, supporting mitochondrial translation and oxidative phosphorylation [4,7] |
| Related process | Mitochondrial transcription regulation by mitochondrial topoisomerase I |
| Related process | RNA-binding protein-mediated mRNA stabilization in metabolic tissues [1,2] |
| Disease relevance | Abdominal aortic aneurysm, colorectal cancer, amyotrophic lateral sclerosis and metabolic disorders [1,3,8] |
| Research methods | CRISPR knockout, RNAi screening, RNA-seq, mitochondrial transcript stability assays [5,6] |
What Is GO:1905638?
In our own words, GO:1905638 refers to any cellular process that reduces the rate, frequency or extent of mitochondrial mRNA catabolic process. This includes mechanisms that protect mitochondrial transcripts from degradation, slow down their turnover, or inhibit the enzymes and complexes responsible for mitochondrial mRNA decay. The term is a negative regulatory process, meaning it acts upstream of or within mitochondrial mRNA catabolism to decrease its activity [4,7].
Why Is negative regulation of mitochondrial mRNA catabolic process Important in Cell Biology?
Negative regulation of mitochondrial mRNA catabolic process is important because mitochondrial mRNAs encode essential subunits of the oxidative phosphorylation complexes, and their stability directly controls cellular ATP production, redox balance and survival. When this regulatory process is impaired, mitochondrial transcripts are degraded too quickly, leading to energy failure and increased sensitivity to stress. Conversely, excessive stabilization can disrupt the stoichiometry of mitochondrial gene expression and contribute to disease. Understanding GO:1905638 therefore provides a mechanistic entry point for therapeutic strategies in metabolic, cardiovascular and neurodegenerative disorders [1,3,4,8].
• Controls mitochondrial mRNA half-life and thus the availability of transcripts for mitochondrial translation [4,7].
• Supports oxidative phosphorylation capacity and cellular ATP production.
• Modulates endothelial barrier function and early abdominal aortic aneurysm progression through ALDH2-LIN28B-ELK3 signaling.
• Regulates adipocyte beiging and thermogenesis via CELF1-mediated stabilization of Dio2 mRNA.
• Influences ferroptosis-mediated energy metabolism disorders in colorectal cancer.
• Is relevant to neurodegeneration, as mitochondrial dynamics are imbalanced in ALS models.
• Provides a mechanistic link between RNA stability and mitochondrial transcription regulation.
• Offers targets for CRISPR-based functional screens in metabolic and cancer biology [5,6].
What Happens During negative regulation of mitochondrial mRNA catabolic process?
Recognition of mitochondrial mRNA targets
In simple terms: First, the cell must identify which mitochondrial mRNAs should be protected from degradation.
Negative regulation of mitochondrial mRNA catabolic process begins with the recognition of specific mitochondrial transcripts by RNA-binding proteins or ribonucleoprotein complexes. These factors distinguish stable transcripts from those destined for decay, often through sequence elements or structural features. Mitochondrial topoisomerase I can influence the transcription and steady-state levels of mitochondrial mRNAs, thereby shaping the pool of transcripts available for catabolism. In skeletal muscle differentiation, Tfam expression is regulated to match mitochondrial transcript demand, indicating that target recognition is developmentally controlled.
Inhibition of mitochondrial mRNA decay machinery
In simple terms: Next, the cell blocks the enzymes that would normally chew up mitochondrial mRNAs.
Once target transcripts are recognized, negative regulators interfere with the nucleases and exonucleases responsible for mitochondrial mRNA catabolism. This can occur through direct protein-protein interactions, competition for binding sites, or sequestration of decay factors. The ALDH2-LIN28B-ELK3 signaling axis improves endothelial barrier function and is associated with early abdominal aortic aneurysm progression, suggesting that RNA stability pathways can modulate mitochondrial mRNA turnover in vascular cells. CELF1 stabilizes Dio2 mRNA in adipocytes, illustrating how RNA-binding proteins can protect transcripts from degradation.
Stabilization of mitochondrial transcripts
In simple terms: The protected mRNAs then remain available for translation for longer periods.
As a result of inhibited catabolism, mitochondrial mRNAs persist and can be translated into proteins of the oxidative phosphorylation system. This stabilization supports mitochondrial function and cellular energy balance. Berberine suppresses colorectal cancer progression by inducing ferroptosis-mediated energy metabolism disorders, a process in which mitochondrial mRNA stability and energy metabolism are intertwined. RNAi screens have identified HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth, highlighting the broader metabolic consequences of mitochondrial transcript regulation.
Feedback and integration with cellular stress responses
In simple terms: Finally, the cell integrates mRNA stabilization with stress signals to fine-tune mitochondrial output.
Negative regulation of mitochondrial mRNA catabolic process is not isolated; it is integrated with transcriptional feedback and stress-responsive pathways. N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis, showing that epitranscriptomic marks can influence mitochondrial stress responses. In Drosophila models of amyotrophic lateral sclerosis, imbalanced mitochondrial dynamics further demonstrate the importance of coordinating mitochondrial RNA regulation with organelle quality control.
Key Genes Involved in GO:1905638 negative regulation of mitochondrial mRNA catabolic process
The following genes and proteins have been experimentally linked to mitochondrial mRNA stability, mitochondrial transcription regulation, or related RNA stabilization pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ALDH2 | Part of ALDH2-LIN28B-ELK3 signaling that improves endothelial barrier function | Linked to early abdominal aortic aneurysm progression and RNA stability |
| LIN28B | RNA-binding protein in ALDH2-LIN28B-ELK3 signaling | Modulates mRNA stability in endothelial cells |
| ELK3 | Transcription factor downstream of ALDH2-LIN28B signaling | Involved in endothelial barrier function and aneurysm progression |
| CELF1 | Adipocyte RNA-binding protein that stabilizes Dio2 mRNA | Promotes beiging of white fat and metabolic remodeling |
| Dio2 | Type 2 iodothyronine deiodinase mRNA stabilized by CELF1 | Regulates thermogenesis and adipocyte beiging |
| TOP1MT | Mitochondrial topoisomerase I that negatively regulates mitochondrial transcription | Directly influences mitochondrial mRNA levels and catabolic flux |
| Tfam | Mitochondrial transcription factor A | Regulates mitochondrial transcript demand during skeletal muscle differentiation |
| HES4 | Regulator of redox balance supporting pyrimidine synthesis | Identified in RNAi screens for tumor growth |
| SLC7A11 | Cystine/glutamate antiporter regulated by m6A modification | Modulates ferroptosis and energy metabolism |
| KDM6B | Histone demethylase involved in m6A-dependent SLC7A11 transcription | Links epitranscriptomics to ferroptosis |
| GATA3 | Transcription factor regulating SLC7A11 | Involved in m6A-dependent ferroptosis modulation |
| SOD1 | Superoxide dismutase 1 | Mitochondrial dynamics are imbalanced in ALS models |
| TDP-43 | RNA-binding protein implicated in ALS | Associated with mitochondrial dysfunction in Drosophila models |
| PINK1 | Mitochondrial kinase involved in mitophagy | Relevant to mitochondrial quality control in neurodegeneration |
| Parkin | E3 ubiquitin ligase in mitophagy | Linked to mitochondrial dynamics in ALS models |
| MFN2 | Mitochondrial fusion protein | Implicated in mitochondrial dynamics imbalance |
| DRP1 | Mitochondrial fission protein | Involved in mitochondrial dynamics in ALS models |
How Is negative regulation of mitochondrial mRNA catabolic process Regulated?
Negative regulation of mitochondrial mRNA catabolic process is controlled at multiple levels. Mitochondrial topoisomerase I can negatively regulate mitochondrial transcription, thereby altering the pool of mRNAs available for catabolism. RNA-binding proteins such as CELF1 stabilize specific transcripts like Dio2 mRNA in adipocytes, providing a mechanism for tissue-specific regulation. The ALDH2-LIN28B-ELK3 signaling axis modulates endothelial RNA stability and barrier function, linking metabolic signals to mitochondrial mRNA turnover. Additionally, m6A RNA modification and its readers influence ferroptosis-related gene expression, suggesting that epitranscriptomic marks participate in the regulation of mitochondrial mRNA stability. In skeletal muscle differentiation, Tfam expression is developmentally regulated to match mitochondrial transcript demand.
negative regulation of mitochondrial mRNA catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALDH2 | Abdominal aortic aneurysm, endothelial barrier function | Endothelial cell knockout and knock-in models |
| CELF1 | Adipocyte beiging, metabolic disorders | Adipocyte-specific overexpression and knockout |
| HES4 | Colorectal cancer, redox balance | Cancer cell line knockout and RNAi screening |
| SLC7A11 | Ferroptosis, energy metabolism disorders | CRISPR point mutation and overexpression models |
| Tfam | Skeletal muscle differentiation, mitochondrial myopathy | Myoblast knockout and tagged knock-in |
Abdominal aortic aneurysm and endothelial barrier dysfunction
Early progression of abdominal aortic aneurysm is decelerated by improved endothelial barrier function via ALDH2-LIN28B-ELK3 signaling, a pathway that involves RNA stability regulation. This suggests that negative regulation of mitochondrial mRNA catabolic process may protect endothelial cells from stress-induced barrier failure. Targeting this pathway could offer therapeutic opportunities for vascular disease.
Colorectal cancer and ferroptosis
Berberine suppresses colorectal cancer progression by inducing ferroptosis-mediated energy metabolism disorders, a process in which mitochondrial mRNA stability and energy metabolism are closely linked. RNAi screens have identified HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth, further connecting mitochondrial transcript regulation to cancer metabolism. N6-methyladenosine RNA modification regulates SLC7A11 transcription through KDM6B and GATA3 to modulate ferroptosis, providing an epitranscriptomic layer to this regulation.
Amyotrophic lateral sclerosis and mitochondrial dynamics
Imbalance of mitochondrial dynamics is observed in Drosophila models of amyotrophic lateral sclerosis, highlighting the importance of mitochondrial RNA regulation in neurodegeneration. Genes such as SOD1, TDP-43, PINK1, Parkin, MFN2 and DRP1 are implicated in these models, suggesting that negative regulation of mitochondrial mRNA catabolic process may influence neuronal survival under stress.
Metabolic disorders and adipose tissue beiging
Adipocyte RNA-binding protein CELF1 promotes beiging of white fat through stabilizing Dio2 mRNA, demonstrating that mRNA stabilization programs are central to metabolic remodeling. This links negative regulation of mitochondrial mRNA catabolic process to thermogenesis and energy expenditure, with potential implications for obesity and metabolic syndrome.
From negative regulation of mitochondrial mRNA catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ALDH2-LIN28B-ELK3 signaling regulate mitochondrial mRNA stability in endothelial cells? | Endothelial cell knockout of ALDH2, LIN28B or ELK3 |
| Does CELF1 stabilize Dio2 mRNA to promote adipocyte beiging? | Adipocyte-specific CELF1 knockout and overexpression |
| Does TOP1MT negatively regulate mitochondrial transcription and mRNA catabolism? | TOP1MT knockout and point-mutation cell lines |
| Does HES4 regulate redox balance and tumor growth? | HES4 knockout in cancer cell lines and xenografts |
| Does m6A modification of SLC7A11 affect ferroptosis? | SLC7A11 point-mutation and knock-in models |
| Does Tfam expression control mitochondrial transcript demand during differentiation? | Tfam knockout and tagged knock-in in myoblasts |
How to Study the negative regulation of mitochondrial mRNA catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state and decay rates of mitochondrial mRNAs | Quantifying transcript stability after transcriptional shutoff |
| RNAi screen | Loss-of-function effects on redox balance and tumor growth | Identifying regulators like HES4 |
| CRISPR knockout screen | Gene deletions that alter mitochondrial mRNA stability | Discovering negative regulators of catabolism |
| Mitochondrial transcript stability assay | Half-life of mitochondrial mRNAs | Testing candidate genes for negative regulation |
| m6A RNA immunoprecipitation | Epitranscriptomic marks on mitochondrial transcripts | Linking m6A to ferroptosis and mRNA stability |
| Proteomics | RNA-binding protein interactions with mitochondrial mRNAs | Identifying stabilizers like CELF1 |
| Mitochondrial respiration assay | Oxidative phosphorylation capacity | Linking mRNA stability to energy metabolism |
| Drosophila genetics | Mitochondrial dynamics in vivo | Modeling ALS-related mitochondrial dysfunction |
RNA-seq and mitochondrial transcript profiling
RNA-seq can quantify mitochondrial mRNA levels and stability after transcriptional shutoff. This approach is used to assess how negative regulators of mitochondrial mRNA catabolic process alter transcript half-lives. Studies of Tfam expression during skeletal muscle differentiation have used transcript profiling to link mitochondrial transcript demand to differentiation state.
RNAi and CRISPR screens
RNAi screens have identified HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth, demonstrating the power of functional genomics to uncover mitochondrial mRNA regulators. CRISPR knockout screens can similarly identify genes that modify mitochondrial mRNA stability and catabolism.
Mitochondrial transcript stability assays
Transcript stability assays using transcriptional inhibitors followed by quantitative PCR or RNA-seq measure the decay rate of mitochondrial mRNAs. These assays are essential to determine whether a candidate gene negatively regulates mitochondrial mRNA catabolic process.
Epitranscriptomic and proteomic analysis
N6-methyladenosine RNA modification regulates SLC7A11 transcription through KDM6B and GATA3 to modulate ferroptosis, illustrating how epitranscriptomic profiling can reveal regulators of mitochondrial stress responses. Proteomics can identify RNA-binding proteins that interact with mitochondrial transcripts and protect them from degradation.
How CRISPR Can Be Used to Study GO:1905638 negative regulation of mitochondrial mRNA catabolic process
Knockout
CRISPR knockout of candidate genes such as ALDH2, CELF1 or TOP1MT can test whether they are required for negative regulation of mitochondrial mRNA catabolic process. Knockout cell lines show altered mitochondrial mRNA half-lives and oxidative phosphorylation capacity, providing causal evidence [1,2,4].
Point Mutation
Point mutations can dissect specific residues required for RNA binding or catalytic activity. For example, point mutations in SLC7A11 can reveal how m6A modification sites affect ferroptosis and mitochondrial mRNA stability. Point-mutation models are also useful for studying TOP1MT catalytic mutants.
Knock-in
Knock-in of tagged alleles, such as GFP or HA tags, allows visualization and immunoprecipitation of endogenous proteins involved in mitochondrial mRNA stabilization. Tagged Tfam knock-in models can track mitochondrial transcription factor A dynamics during differentiation.
Overexpression
Overexpression of stabilizers like CELF1 or LIN28B can test whether increased protein levels enhance mitochondrial mRNA stability and metabolic remodeling. Overexpression models are particularly useful for studying adipocyte beiging and endothelial barrier function [1,2].
How EDITGENE Supports negative regulation of mitochondrial mRNA catabolic process Research
Researchers studying negative regulation of mitochondrial mRNA catabolic process-related genes often need to determine whether a candidate gene is causally involved in transcript stabilization, mitochondrial function or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to enable these functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mitochondrial mRNA catabolic process research.
Frequently Asked Questions About negative regulation of mitochondrial mRNA catabolic process
What is GO:1905638?
GO:1905638 is the Gene Ontology term for negative regulation of mitochondrial mRNA catabolic process, describing any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial mRNA catabolic process.
What genes are involved in negative regulation of mitochondrial mRNA catabolic process?
Genes such as ALDH2, LIN28B, ELK3, CELF1, TOP1MT, Tfam and HES4 have been linked to mitochondrial mRNA stability and related RNA regulation pathways [1,2,4,5,7].
How is mitochondrial mRNA stability regulated?
Mitochondrial mRNA stability is regulated by RNA-binding proteins that protect transcripts from nucleases, by mitochondrial topoisomerase I that modulates transcription, and by epitranscriptomic marks such as m6A [2,4,6].
Why is negative regulation of mitochondrial mRNA catabolic process important in cancer?
It influences energy metabolism and ferroptosis sensitivity; berberine suppresses colorectal cancer by inducing ferroptosis-mediated energy metabolism disorders, and HES4 regulates redox balance supporting tumor growth [3,5].
What diseases are associated with mitochondrial mRNA catabolic process?
Abdominal aortic aneurysm, colorectal cancer, amyotrophic lateral sclerosis and metabolic disorders have been associated with dysregulation of mitochondrial mRNA stability and dynamics [1,3,8].
How can CRISPR be used to study mitochondrial mRNA stability?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of candidate genes in mitochondrial mRNA stabilization and catabolism [1,5,6].
What methods measure mitochondrial mRNA decay?
RNA-seq after transcriptional shutoff, mitochondrial transcript stability assays and m6A RNA immunoprecipitation are commonly used to measure mitochondrial mRNA decay rates [4,6].
Is CELF1 involved in mitochondrial mRNA regulation?
CELF1 is an adipocyte RNA-binding protein that stabilizes Dio2 mRNA to promote beiging of white fat, demonstrating its role in mRNA stabilization.
What is the role of TOP1MT in mitochondrial mRNA regulation?
Mitochondrial topoisomerase I (TOP1MT) negatively regulates mitochondrial transcription, thereby influencing mitochondrial mRNA levels and catabolic flux.
How does m6A modification affect mitochondrial mRNA stability?
N6-methyladenosine RNA modification regulates SLC7A11 transcription through KDM6B and GATA3 to modulate ferroptosis, linking epitranscriptomic marks to mitochondrial stress responses.
Conclusion
GO:1905638, negative regulation of mitochondrial mRNA catabolic process, is a critical biological process that controls the stability of mitochondrial transcripts and thereby influences oxidative phosphorylation, cellular metabolism and stress responses. Key regulators include RNA-binding proteins such as CELF1 and LIN28B, mitochondrial topoisomerase I, and epitranscriptomic modifiers like m6A [1,2,4,6]. Dysregulation of this process is linked to abdominal aortic aneurysm, colorectal cancer, amyotrophic lateral sclerosis and metabolic disorders [1,3,8]. CRISPR-based cell models, including knockout, point-mutation, knock-in and overexpression, provide powerful tools to dissect the causal roles of candidate genes in mitochondrial mRNA stabilization. Combined with RNA-seq, m6A profiling and proteomics, these approaches will accelerate the discovery of therapeutic targets for diseases rooted in mitochondrial RNA dysregulation [5,6,7].
References
- 1. Yang K et al.. 2023. Early Progression of Abdominal Aortic Aneurysm is Decelerated by Improved Endothelial Barrier Function via ALDH2-LIN28B-ELK3 Signaling.. Adv Sci (Weinh) 10(32):e2302231 PMID: 37822152
- 2. Zeng T et al.. 2025. Adipocyte RNA-binding protein CELF1 promotes beiging of white fat through stabilizing Dio2 mRNA.. Nat Commun 16(1):7414 PMID: 40789858
- 3. Sun Q et al.. 2026. Berberine suppresses colorectal cancer progression by inducing ferroptosis-mediated energy metabolism disorders.. J Adv Res 85:1153-1173 PMID: 41139018
- 4. Sobek S et al.. 2013. Negative regulation of mitochondrial transcription by mitochondrial topoisomerase I.. Nucleic Acids Res 41(21):9848-57 PMID: 23982517
- 5. He J et al.. 2024. RNAi screens identify HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth.. Nat Struct Mol Biol 31(9):1413-1425 PMID: 38769389
- 6. Zhang H et al.. 2025. N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis.. J Biomed Sci 32(1):8 PMID: 39800682
- 7. Collu-Marchese M et al.. 2015. The regulation of mitochondrial transcription factor A (Tfam) expression during skeletal muscle cell differentiation.. Biosci Rep 35(3) PMID: 26182383
- 8. Altanbyek V et al.. 2016. Imbalance of mitochondrial dynamics in Drosophila models of amyotrophic lateral sclerosis.. Biochem Biophys Res Commun 481(3-4):259-264 PMID: 27810362
